Skip to main content

Table 4 FcγRIIA-131/FcγRIIIA-176/FcγRIIIB haplotypes distribution within the study groups and association with severe malarial anemia

From: Association between Fcγ receptor IIA, IIIA and IIIB genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya

FcγRIIA-131His/Arg, FcγRIIIA-176F/V and FcγRIIIB-NA1/NA2 haplotypes

Study groups

P-value*

SMA (Hb < 6.0 g/dL

SMA

n (%)

non-SMA

n (%)

OR

95% CI

P-value**

131Arg/176F/NA2 (n = 171)

79 (69.3)

92 (57.5)

0.044

1.70

1.02–2.93

0.036

131His/176F/NA1 (n = 59)

30 (26.3)

29 (18.1)

0.104

1.80

0.98–3.30

0.057

131His/176F/NA2 (n = 87)

32 (28.1)

55 (34.4)

0.269

0.76

0.44–1.32

0.334

131His/176 V/NA1 (n = 79)

28 (24.6)

51 (31.9)

0.188

0.71

0.41–1.25

0.234

  1. Children with acute malaria (n = 274) were grouped based on SMA (defined as Hb < 6.0 g/dL, with any density parasitemia) [25]. Odds ratios (OR) and 95% confidence intervals (CI) were determined using bivariate logistic regression controlling for age, gender, co-infections (HIV-1 and bacteremia) sickle cell trait (HbAS), alpha-thalassemia and G6PD deficiency. The reference groups in the regression analysis were the non-carriage of respective haplotypic structures. n; the number of participants with the respective haplotype. n (%); number (percentage) of participants with respective haplotype in each study group. *P-value determined using Chi-square (χ2). **P-values determined using logistics regression analysis. All P-values were considered statistically significant at P ≤ 0.05
  2. Values in bold are significant p-values at a cut-off of p≤0.05